New biomarkers for drug-induced liver injury: are they really better? what do they diagnose?

被引：10
作者：
Senior, John R. [1 ]
机构：
[1] US FDA, Off Pharmacovigilance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源：
LIVER INTERNATIONAL | 2014年 / 34卷 / 03期
关键词：
ALANINE AMINOTRANSFERASE; MECHANISTIC BIOMARKERS; TRANSAMINASE-ACTIVITY; HEPATOTOXICITY; KERATIN-18;
D O I：
10.1111/liv.12384
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：325 / 327
页数：3
相关论文
共 14 条
[1]   Mechanistic biomarkers in acute liver injury: Are we there yet? [J].
Adebayo, Danielle ;
Mookerjee, Rajeshwar P. ;
Jalan, Rajiv .
JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1003-1005
[2]   RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity (Publication with Expression of Concern. See vol. 73, pg. 1297, 2020) (Publication with Expression of Concern. See vol. 69, pg. 1402, 2018) (Retracted article. See vol. 73, pg. 1297, 2020) [J].
Antoine, Daniel J. ;
Jenkins, Rosalind E. ;
Dear, James W. ;
Williams, Dominic P. ;
McGill, Mitchell R. ;
Sharpe, Matthew R. ;
Craig, Darren G. ;
Simpson, Kenneth J. ;
Jaeschke, Hartmut ;
Park, B. Kevin .
JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1070-1079
[3]   TRANSAMINASE ACTIVITY IN HUMAN BLOOD [J].
KARMEN, A ;
WROBLEWSKI, F ;
LADUE, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (01) :126-133
[4]   SERUM UDP-GALACTOSYL TRANSFERASE AS A POTENTIAL BIOMARKER FOR BREAST-CARCINOMA [J].
PAONE, JF ;
WAALKES, TP ;
ROBINSONBAKER, R ;
SHAPER, JH .
JOURNAL OF SURGICAL ONCOLOGY, 1980, 15 (01) :59-66
[5]   Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans [J].
Rafter, Ingalill ;
Graberg, Truls ;
Kotronen, Anna ;
Strommer, Lovisa ;
Mattson, C. Mikael ;
Kim, Ray W. ;
Ehrenborg, Ewa ;
Andersson, Hakan B. ;
Yki-Jarvinen, Hannele ;
Schuppe-Koistinen, Ina ;
Ekblom, Bjorn ;
Cotgreave, Ian ;
Glinghammar, Bjorn .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (05) :1241-1249
[6]   Causality Assessment in Drug-Induced Liver Injury Using a Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method [J].
Rockey, Don C. ;
Seeff, Leonard B. ;
Rochon, James ;
Freston, James ;
Chalasani, Naga ;
Bonacini, Maurizio ;
Fontana, Robert J. ;
Hayashi, Paul H. .
HEPATOLOGY, 2010, 51 (06) :2117-2126
[7]   Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts [J].
Thulin, Petra ;
Nordahl, Gunnar ;
Gry, Marcus ;
Yimer, Getnet ;
Aklillu, Eleni ;
Makonnen, Eyasu ;
Aderaye, Getachew ;
Lindquist, Lars ;
Mattsson, C. Mikael ;
Ekblom, Bjorn ;
Antoine, Daniel J. ;
Park, B. Kevin ;
Linder, Stig ;
Harrill, Alison H. ;
Watkins, Paul B. ;
Glinghammar, Bjorn ;
Schuppe-Koistinen, Ina .
LIVER INTERNATIONAL, 2014, 34 (03) :367-378
[8]  
Vecchio TJ, 1966, NEW ENGL J MED, V274, P471
[9]   Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH) Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or Knee Replacement Surgery [J].
Watkins, Paul B. ;
Desai, Mehul ;
Berkowitz, Scott D. ;
Peters, Gary ;
Horsmans, Yves ;
Larrey, Dominique ;
Maddrey, Willis .
DRUG SAFETY, 2011, 34 (03) :243-252
[10]  
WEBB KS, 1980, INVEST UROL, V17, P401
12